Utama › Kanser (semua jenis) › California › Mountain View
Kajian klinikal Kanser (semua jenis) di Mountain View, CA
40 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Mountain View (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- Stanford University School of Medicine, Stanford · 5 mi jauh
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Stanford University, Palo Alto · 5 mi jauh
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 5, Stanford · 5 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5 mi jauh
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- Stanford Cancer Center, Stanford · 5 mi jauh
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Mengambil pesertaFasa 1
- Investigational Site Number: 403, Palo Alto · 5 mi jauh
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Research Site, Palo Alto · 5 mi jauh
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- Stanford, Palo Alto · 5 mi jauh
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- Stanford University, Stanford · 5 mi jauh
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Stanford University, Palo Alto · 5 mi jauh
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi jauh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi jauh
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaFasa 1
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauh
- dan 1 lagi
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 150, Palo Alto · 5 mi jauh
Evaluation of Grief Therapy Approaches for Bereaved Parents
Mengambil peserta
- Stanford University (Data Collection Only), Stanford · 5 mi jauh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi jauh
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Stanford University School of Medicine, Stanford · 5 mi jauh
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5 mi jauh
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Stanford University, Stanford · 5 mi jauh
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Mengambil pesertaFasa 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauh
Galleri® in the Medicare Population.
Mengambil pesertaSukarelawan sihat dialu-alukan
- Sutter Valley Hospitals PAMF Sutter, Palo Alto · 5 mi jauh
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Mengambil pesertaFasa 1
- GSK Investigational Site, Stanford · 5 mi jauh
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Mengambil pesertaFasa 1/2
- Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi jauh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauh
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Stanford University School of Medicine, Stanford · 5 mi jauh
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Mengambil pesertaFasa 2
- Byers Eye Institute at Stanford University, Palo Alto · 5 mi jauh
Engagement of Veterans With Lung Cancer
Mengambil peserta
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi jauh
Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
Mengambil pesertaSukarelawan sihat dialu-alukan
- Stanford University, Palo Alto · 5 mi jauh
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Stanford University School of Medicine, Stanford · 5 mi jauh
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Mengambil peserta
- Stanford University, Palo Alto · 5 mi jauh
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Stanford Cancer Institute, Palo Alto · 5 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauh
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
Mengambil pesertaKajian pemerhatian
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Exai Bio Inc., Palo Alto · 5 mi jauh
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Stanford Cancer Institute, Palo Alto · 5 mi jauh
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Mengambil pesertaFasa 1/2
- Stanford University Cancer Institute, Stanford · 5 mi jauh
xPedite: A Study to Expedite DIPG and DMG Research
Mengambil pesertaKajian pemerhatian
- xCures, Inc., Los Altos · 2 mi jauh
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Mountain View
- Kanser Payudara25 kajian
- Kanser Metastatik25 kajian
- Kanser Paru-paru Bukan Sel Kecil21 kajian
- Leukemia Mieloid Akut19 kajian
- Kanser Ovari19 kajian
- Gangguan Spektrum Autisme17 kajian
- Kanser Paru-paru17 kajian
- Kegagalan Jantung15 kajian
- Kanser Prostat15 kajian
- Autisme13 kajian
- Leukemia Limfoblastik Akut13 kajian
- Kanser Kolorektal13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.